NO150205C - Analogifremgangsmaate ved fremstilling av terapeutisk aktive, substituerte heksahydrobenzopyrano(3-2-c)pyridiner - Google Patents

Analogifremgangsmaate ved fremstilling av terapeutisk aktive, substituerte heksahydrobenzopyrano(3-2-c)pyridiner

Info

Publication number
NO150205C
NO150205C NO782184A NO782184A NO150205C NO 150205 C NO150205 C NO 150205C NO 782184 A NO782184 A NO 782184A NO 782184 A NO782184 A NO 782184A NO 150205 C NO150205 C NO 150205C
Authority
NO
Norway
Prior art keywords
hydrobenzopyrano
pyridines
preparation
therapeutically active
analogy procedure
Prior art date
Application number
NO782184A
Other languages
English (en)
Other versions
NO782184L (no
NO150205B (no
Inventor
Philippe Briet
Jean-Claude Depin
Jean-Jacques Berthelon
Original Assignee
Lipha
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR7719360A external-priority patent/FR2395270A1/fr
Priority claimed from FR7816376A external-priority patent/FR2427336A2/fr
Application filed by Lipha filed Critical Lipha
Publication of NO782184L publication Critical patent/NO782184L/no
Publication of NO150205B publication Critical patent/NO150205B/no
Publication of NO150205C publication Critical patent/NO150205C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
    • C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
    • C07D311/14—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted in position 6 and unsubstituted in position 7
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
    • C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
    • C07D311/12—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted in position 3 and unsubstituted in position 7
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
    • C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
    • C07D311/16—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted in position 7

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
NO782184A 1977-06-24 1978-06-22 Analogifremgangsmaate ved fremstilling av terapeutisk aktive, substituerte heksahydrobenzopyrano(3-2-c)pyridiner NO150205C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR7719360A FR2395270A1 (fr) 1977-06-24 1977-06-24 Hexahydro benzopyrano (3,2-c) pyridines substituees, utilisables notamment comme medicaments
FR7816376A FR2427336A2 (fr) 1978-06-01 1978-06-01 Hexahydro benzopyrano (3,2-c) pyridines substituees utilisables notamment comme medicament

Publications (3)

Publication Number Publication Date
NO782184L NO782184L (no) 1978-12-28
NO150205B NO150205B (no) 1984-05-28
NO150205C true NO150205C (no) 1984-09-05

Family

ID=26220098

Family Applications (1)

Application Number Title Priority Date Filing Date
NO782184A NO150205C (no) 1977-06-24 1978-06-22 Analogifremgangsmaate ved fremstilling av terapeutisk aktive, substituerte heksahydrobenzopyrano(3-2-c)pyridiner

Country Status (22)

Country Link
US (1) US4201783A (no)
EP (1) EP0000306B1 (no)
JP (1) JPS5412399A (no)
AR (1) AR225732A1 (no)
AT (1) AT356662B (no)
AU (1) AU519417B2 (no)
CA (1) CA1098519A (no)
CS (1) CS207624B2 (no)
DD (1) DD137441A5 (no)
DE (1) DE2860016D1 (no)
DK (1) DK158311C (no)
ES (1) ES471060A1 (no)
HU (1) HU177341B (no)
IE (1) IE46999B1 (no)
IL (1) IL54953A (no)
IN (1) IN151192B (no)
IT (1) IT1097257B (no)
MX (1) MX5090E (no)
NO (1) NO150205C (no)
NZ (1) NZ187629A (no)
SU (1) SU931108A3 (no)
YU (1) YU40338B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2522666A1 (en) * 2003-04-18 2004-10-28 Pharmacia & Upjohn Company Llc Combination therapies for chronic obstructive pulmonary disease (copd)
EP2563839B1 (de) 2010-04-30 2014-12-17 Basf Se Polyetherpolyole, verfahren zur herstellung von polyetherpolyolen, sowie deren verwendung zur herstellung von polyurethanen
US9434975B2 (en) * 2011-03-30 2016-09-06 3M Innovative Properties Company Fluorogenic or fluorophoric compounds and uses thereof
JP7209475B2 (ja) 2018-04-09 2023-01-20 日産自動車株式会社 電池の製造方法
CN111617254B (zh) * 2020-07-02 2022-04-26 中国人民解放军军事科学院军事医学研究院 降低mysm1含量或活性的物质在治疗抑郁症中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3549641A (en) * 1966-06-28 1970-12-22 Warner Lambert Pharmaceutical Pyrano pyridines and process for their production
US3673194A (en) * 1970-05-04 1972-06-27 American Cyanamid Co DERIVATIVES OF 1,4,4a,9b-TETRAHYDRO-8,9b-DIMETHYL-2-PHENYL-1,4-ETHANOBENZOFURO {8 3,2-C{9 PYRIDINE-3(2H), 10-DIONE
US4033968A (en) * 1976-04-14 1977-07-05 Merck & Co., Inc. Diazatetracyclododecanes

Also Published As

Publication number Publication date
IT1097257B (it) 1985-08-31
HU177341B (en) 1981-09-28
DK158311C (da) 1990-10-08
IT7824705A0 (it) 1978-06-19
MX5090E (es) 1983-03-15
IL54953A (en) 1984-06-29
YU40338B (en) 1985-12-31
AU3746378A (en) 1980-01-03
ES471060A1 (es) 1979-01-01
ATA464478A (de) 1979-10-15
CS207624B2 (en) 1981-08-31
US4201783A (en) 1980-05-06
AT356662B (de) 1980-05-12
IL54953A0 (en) 1978-08-31
EP0000306B1 (fr) 1980-05-28
DD137441A5 (de) 1979-09-05
JPS5412399A (en) 1979-01-30
NZ187629A (en) 1981-03-16
NO782184L (no) 1978-12-28
DK281978A (da) 1978-12-25
DK158311B (da) 1990-04-30
NO150205B (no) 1984-05-28
DE2860016D1 (en) 1980-10-16
IE46999B1 (en) 1983-11-30
IE781239L (en) 1978-12-24
AR225732A1 (es) 1982-04-30
CA1098519A (fr) 1981-03-31
YU143878A (en) 1982-10-31
JPS633866B2 (no) 1988-01-26
SU931108A3 (ru) 1982-05-23
AU519417B2 (en) 1981-12-03
EP0000306A1 (fr) 1979-01-10
IN151192B (no) 1983-03-05

Similar Documents

Publication Publication Date Title
NO151085C (no) Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive peptidylargininaldehydderivater
NO153136C (no) Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive naftyridinderivater.
NO149962C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive imidazolderivater
NO149662C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive c-076-forbindelser
NO160211C (no) Analogifremgangsmaate til fremstilling av nye terapeutisk virksomme cefemderivater.
NO149174C (no) Analogifremgangsmaate ved fremstilling av nye terapeutisk virksomme tiazinderivater
NO154346C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive ftalazin-4-yl-eddiksyrederivater.
NO156611C (no) Analogifremgangsmaate for fremstilling av terapeutiske virksomme derivater av hydroksykarbonylfosfonsyre.
NO158540C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 2-penem-forbindelser.
NO147148C (no) Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive fenyletanolaminderivater
NO149733C (no) Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive acylderivater av carnitin
NO152841C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive nye 4-aroylimidazol-2-oner.
NO154522C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme kinolinderivater.
NO145307C (no) Analogifremgangsmaate ved fremstilling av nye terapeutisk virksomme nucleosider
NO152654C (no) Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive derivater av 7-acylamido-3-cephem-4-karboksylsyre
NO784393L (no) Fremgangsmaate ved fremstilling av anti-allergisk aktive pyrimidin-derivater
NO147953C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive antracyklinglukosider
NO148642C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive, nye prostacyclinderivater
NO146095C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive kinazolin-derivater
NO143225C (no) Analogifremgangsmaate ved fremstilling av terapeutisk virksomme tetrahydrothieno-(3,2-c)pyridinderivater
NO147150C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive piperidiner.
NO154920C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive, nye pyridothienotriaziner.
NO150041C (no) Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive lactamforbindelser
NO148070C (no) Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive angiotensin ii analoger
NO148454C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolidin-dionderivater